Palvella Therapeutics (PVLA) Enterprise Value Growth (1y) (2014 - 2026)
Palvella Therapeutics (PVLA) Enterprise Value Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -246.25% |
| Dec 31, 2025 | 30.65% |
| Sep 30, 2025 | -347.43% |
| Jun 30, 2025 | -384.51% |
| Mar 31, 2025 | -1,110.40% |
| Dec 31, 2024 | -412.27% |
| Sep 30, 2024 | 74.95% |
| Jun 30, 2024 | 77.58% |
| Mar 31, 2024 | 89.05% |
| Dec 31, 2023 | 72.42% |
| Sep 30, 2023 | 37.81% |
| Jun 30, 2023 | 19.89% |
| Mar 31, 2023 | 43.12% |
| Dec 31, 2022 | 49.76% |
| Sep 30, 2022 | -161.32% |
| Jun 30, 2022 | 11.83% |
| Mar 31, 2022 | -50.02% |
| Dec 31, 2021 | -67.19% |
| Sep 30, 2021 | 57.77% |
| Jun 30, 2021 | -18.89% |